Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Validation of Saliva in the Esoterix Genetic Laboratories Fragile X Assay

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Esoterix Genetic Laboratories, LLC.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Esoterix Genetic Laboratories, LLC
ClinicalTrials.gov Identifier:
NCT01616589
First received: June 7, 2012
Last updated: NA
Last verified: June 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)